Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital

Can fecal microbiota transplantation cure irritable bowel syndrome?

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review


  1. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Accuracy of abdominal auscultation for bowel obstruction

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

AIM: To verify the utility of treatment with fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome (IBS).

METHODS: We searched EMBASE, Cochrane Library and PubMed in March, 2017. The reviewed literature was based on two systematic searches in each of the databases. The MeSH terms used were IBS and fecal microbiota transplantation and the abbreviations IBS and FMT. Reference lists from the articles were reviewed to identify additional pertinent articles.

RESULTS: A total of six conference abstracts, one case report, one letter to the editor, and one clinical review were included. In the final analysis, treatment of 48 patients was evaluated. Treatment revealed an improvement in 58% of cases. The varying structure of the nine included studies must be taken into consideration.

CONCLUSION: Data on FMT and IBS are too limited to draw sufficient conclusions. Standardized double blinded randomized clinical trials need to be carried out to evaluate the effect of FMT on IBS.

TidsskriftWorld Journal of Gastroenterology
Udgave nummer22
Sider (fra-til)4112-4120
StatusUdgivet - 1 jun. 2017

ID: 50650341